Symbol: |
CAND2
|
Description: |
cullin-associated and neddylation-dissociated 2 (putative) [Source:HGNC Symbol;Acc:30689]
|
Location: |
Chr3:12837971-12913415[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:121
Gene |
Compound |
Gen_sig |
Exp_pattern |
CAND2 |
NSC 719252 |
0.018 |
Down |
CAND2 |
NSC 720258 |
0.03 |
Down |
CAND2 |
NSC 720433 |
0.033 |
Down |
CAND2 |
(-)-Dibenzylnortrachelogenin |
0.001 |
Down |
CAND2 |
NSC 723378 |
0.002 |
Down |
CAND2 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.041 |
Down |
CAND2 |
N,N' Bis{2-(4-phenylene)benzimidazole}thiourea |
0.037 |
Down |
CAND2 |
NSC 726881 |
0.023 |
Up |
CAND2 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.023 |
Down |
CAND2 |
Everolimus |
0.022 |
Up |
CAND2 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.024 |
Up |
CAND2 |
6-(10'-tert-BOC-aminododecyl)-5,6-dihydro-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline |
0.014 |
Up |
CAND2 |
6-(3-Azidopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.017 |
Up |
CAND2 |
Furan-2-yl-(1-oxy-3,6-bis-trifluoromethyl-quinoxalin-2-yl)-methanone |
0.014 |
Up |
CAND2 |
NSC 745624 |
0.016 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:8
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:12
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:21
Total:2 Current:1
[First] [Prev]  Next Last 
|